| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Satellogic Inc.
13D/A
Amendment 5
SATL · G7823S101
|
0% |
3/26/2026
Event 3/24/2026
|
|||
|
M3-Brigade Acquisition V Corp.
13D/A
Amendment 1
VLOS · G63212107
|
27.1% |
3/2/2026
Event 2/26/2026
|
|||
| Cantor Fitzgerald, L.P. | 27.1% | ||||
| CF Group Management, Inc. | 27.1% | ||||
| Cantor Fitzgerald & Co. | 27.1% | ||||
| Cantor Fitzgerald Securities | 27.1% | ||||
| Brandon Lutnick | 27.1% | ||||
|
Sono Group N.V.
13G
SEVCF · N81409109
|
7.0% |
2/13/2026
Event 9/30/2025
|
|||
| Cantor Fitzgerald Securities | 7.0% | ||||
| Cantor Fitzgerald & Co. | 7.0% | ||||
| Cantor Fitzgerald, L.P. | 7.0% | ||||
| CF Group Management, Inc. | 7.0% | ||||
| Brandon G. Lutnick | 7.0% | ||||
|
M3-Brigade Acquisition V Corp.
13D
VLOS · G63212107
|
27.1% |
12/19/2025
Event 12/12/2025
|
|||
| Cantor Fitzgerald, L.P. | 27.1% | ||||
| CF Group Management, Inc. | 27.1% | ||||
| Cantor Fitzgerald & Co. | 27.1% | ||||
| Cantor Fitzgerald Securities | 27.1% | ||||
| Brandon Lutnick | 27.1% | ||||
|
OnKure Therapeutics Inc.
13G
OKUR · 68277Q105
|
5.2% |
8/14/2025
Event 6/30/2025
|
|||
| Cantor Fitzgerald Securities | 5.2% | ||||
| Cantor Fitzgerald & Co. | 5.2% | ||||
| Cantor Fitzgerald, L.P. | 5.2% | ||||
| CF Group Management, Inc. | 5.2% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.